STOK
Stoke Therapeutics Inc
NASDAQ: STOK · HEALTHCARE · BIOTECHNOLOGY
$32.42
-2.73% today
Updated 2026-04-29
Market cap
$1.92B
P/E ratio
—
P/S ratio
10.40x
EPS (TTM)
$-0.12
Dividend yield
—
52W range
$8 – $40
Volume
0.8M
Stoke Therapeutics Inc (STOK) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-5.38M | $-10.96M | $-31.05M | $-42.22M | $-66.91M | $-31.87M | $-81.07M | $-86.85M | $45.59M |
| Capital expenditures | $113000.00 | $935000.00 | $1.64M | $1.05M | $1.20M | $3.96M | $1.62M | $203000.00 | $670000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $26000.00 | $240000.00 | $1.92M | $5.77M | $16.45M | $22.85M | $25.26M | $27.47M | $32.24M |
| Free cash flow | $-5.50M | $-11.90M | $-32.69M | $-43.27M | $-68.11M | $-35.83M | $-82.68M | $-87.05M | $44.91M |
| Investing cash flow | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — |
| Dividends paid | $0.00 | $0.00 | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $64.84M | $-142.05M | $-31.34M | — | — | — |